Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15790 articles
A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers.
Neoadjuvant radiochemotherapy may improve OS in patients with stage II/III high rectal cancers.
»
10/29/18
Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Lower protein level of ALKBH1 closely correlated with larger tumor sizes.
»
06/18/18
A low albumin to globulin ratio with a high serum globulin level is a prognostic marker for poor survival in cervical cancer patients treated with radiation based therapy.
γ-globulin fraction most strongly correlated with the globulin levels.
»
07/19/18
Molecular characterization of low grade and high grade bladder cancer.
Unsupervised hierarchical clustering based on gene expression data identified four distinct molecular groups.
»
04/05/18
Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
ccfDNA emerged as highly potent predictive classifier.
»
08/22/18
Effects of 5-ALA dose on resection of glioblastoma.
Gross total resection more likely in the high dose group.
»
11/27/18
Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway
Overexpression of OTUD6B-AS1 decreased activity of Wnt/β-catenin pathway.
»
01/22/19
JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer
Colon cancer cells can evade JAK2/JAK1-targeted therapy by reversible shift of RAS-MEK-ERK pathway.
»
01/22/19
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
HER2-overexpressing cell lines demonstrate increased sensitivity to targeted HIF-2α inhibition.
»
01/22/19
Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
LTX-315 displayed strong additive antitumoral effect when used in combination with CAELYX®.
»
01/22/19
< Prev
Next >